Edward Morrow Atkinson III sold $803K of Vertex Pharmaceuticals Incorporated (VRTX)

Executed Feb 11 2025, disclosed Feb 12 2025, 1 day later.

Value, as filed

$803K

1,747 sh × $459.83

Executed

Feb 11 2025

the trade date, as filed

Disclosed

Feb 12 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

EI Edward Morrow Atkinson III EVP, Chief Technical Ops. Off. profile →

Edward Morrow Atkinson III (EVP, Chief Technical Ops. Off.) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Vertex Pharmaceuticals Incorporated (VRTX). The largest single filing was $1.4M of VRTX (2,848 sh across 2 lots, as filed), executed Feb 17.

The name

VRTX Vertex Pharmaceuticals Incorporated VRTX · Healthcare · 91 filings in 24 months ticker →

Healthcare · Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Edward Morrow Atkinson III in VRTX

VRTXSALE Vertex Pharmaceuticals Incorporated $325K
668 sh × $486.35
Exec Feb 25
Filed Feb 26 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $1.4M
2,848 sh across 2 lots
Exec Feb 17
Filed Feb 19 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $806K
1,751 sh × $460.43
Exec Feb 11
Filed Feb 12 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $1.1M
2,500 sh × $434.58
Exec Nov 17 2025
Filed Nov 19 2025 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $1.3M
2,650 sh × $475.34
Exec Feb 27 2025
Filed Feb 28 2025 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $850K
1,767 sh × $480.95
Exec Feb 25 2025
Filed Feb 26 2025 · 5:30 PM ET